Intra Cellular Therapies shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Balyasny Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $26M | 360k | 71.62 |
| 2023-06-30 | $8.3M | 131k | 63.32 |
| 2023-03-31 | $397k | 7.3k | 54.15 |
| 2022-12-31 | $35k | 668 | 52.92 |
| 2022-09-30 | $247k | 5.3k | 46.53 |
| 2022-03-31 | $2.0M | 32k | 61.19 |
| 2018-09-30 | $11M | 509k | 21.70 |
| 2018-06-30 | $8.1M | 458k | 17.67 |
| 2018-03-31 | $8.5M | 402k | 21.05 |
| 2017-12-31 | $1.6M | 110k | 14.48 |
| 2017-09-30 | $2.2M | 139k | 15.78 |
| 2016-03-31 | $1.5M | 55k | 27.80 |
| 2015-12-31 | $504k | 9.4k | 53.79 |
| 2015-09-30 | $1.2M | 30k | 40.03 |
| 2015-06-30 | $1.6M | 50k | 31.96 |